Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors.
Kato Y, Kawasaki M, Nigo T, Nakamura S, Fusano A, Teranishi Y, Ito MN, Sumiyoshi T.
A series of 2,3-disubstituted pyridines were synthesized and evaluated for their PDE4 inhibitory activity. We successfully modified undesirable cyano group of initial lead compound 2 to 4-pyridyl group with improvement of in vitro efficacy and optimized the position of nitrogen atoms in pyridine moiety and alkylene linker. The most potent compound showed significant efficacy in animal models of asthma and inflammation.